We investigated whether cell proliferation and neurogenesis are altered in R6/2 transgenic Huntington's disease mice. Using bromodeoxyuridine (BrdU), we found a progressive decrease in the number of proliferating cells in the dentate gyrus of R6/2 mice. This reduction was detected in pre-symptomatic mice, and by 11.5 weeks, R6/2 mice had 66% fewer newly born cells in the hippocampus. The results were confirmed by immunohistochemistry for the cell cycle markers Ki-67 and proliferating cell nuclear antigen (PCNA). We did not observe changes in cell proliferation in the R6/2 subventricular zone, indicating that the decrease in cell proliferation is specific for the hippocampus. This decrease corresponded to a reduction in actual hippocampal neurogenesis as assessed by double immunostaining for BrdU and the neuronal marker neuronal nuclei (NeuN) and by immunohistochemistry for the neuroblast marker doublecortin. Reduced hippocampal neurogenesis may be a novel neuropathological feature in R6/2 mice that could be assessed when evaluating potential therapies. D
Introduction
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by an expanded CAG repeat in the HD gene, which encodes for huntingtin, a large cytoplasmic protein of yet unknown function (HDCRG, 1993) . The disease is invariably fatal and affected individuals show depression, a severe motor impairment, dementia, and weight loss. The neuropathology of the disease is characterized by accumulation of huntingtin in neuronal intranuclear inclusions, as well as a progressive degeneration of neurons in the striatum, certain layers of the cerebral cortex, and the hypothalamus (for review, Petersén and Brundin, 2002; Vonsattel and DiFiglia, 1998) . The most used animal model for studying the mechanisms underlying the pathogenesis of HD is the R6/2 transgenic mouse model, which expresses exon 1 of human mutant HD gene with approximately 150 CAG repeats (Mangiarini et al., 1996) . R6/2 mice display several features of the human condition, including progressive motor (Carter et al., 1999) and cognitive impairments (Lione et al., 1999; Murphy et al., 2000) , weight loss, decreased striatal and brain size (Mangiarini et al., 1996) , ubiquitinated nuclear and cytoplasmic inclusions of mutant huntingtin (Davies et al., 1997) , altered levels of neurotransmitters (Cha, 2000) and their receptors (Cha et al., 1998) , decreased expression of striatal signaling genes (Luthi-Carter et al., 2000) , and premature death (Mangiarini et al., 1996) . Relatively little neuronal death has been detected in the striatum and cerebral cortex of R6/2 mice (Iannicola et al., 2000; Turmaine et al., 2000) . However, we recently described a progressive loss of orexin neurons in the lateral hypothalamus of these transgenic HD mice (Petersén et al., 2005) . A loss of retinal ganglion neurons has also been reported (Helmlinger et al., 2002) .
Although initially thought to occur only during embryonic development, recent studies have shown that neurogenesis occurs throughout life and that there are significant numbers of neural precursors in several regions of the adult mammalian brain. In fact, proliferation and differentiation of new neurons are now known to occur in selective regions of the adult brain, primarily in the subventricular zone (SVZ) of the lateral ventricles and in the subgranular zone (SGZ) of the dentate gyrus (DG) of the hippocampus. Given this capacity of the adult brain to generate
